Ads
related to: sanofi- Type 1 Diabetes FAQs
Get Answers to Your FAQs About
T1D and Screening Early for T1D
- What You Need to Know
Learn the Risk Factors of T1D.
Take the Type 1 Risk Quiz
- T1D Risk Factors
Take the Type 1 Risk Quiz to
Understand Your Risk Factor for T1D
- Know Your Options
Screen Early for Type 1 Diabetes &
Start Planning for the Future.
- Screen Early
Talk to Your Doctor About
Screening Early for T1D
- Screen Early for T1D
Learn the Importance of
Screening Early
- Type 1 Diabetes FAQs
Search results
J&J (JNJ) to Buy Rights to Novel Atopic Dermatitis Candidate
Zacks via Yahoo Finance· 1 day agoJ&J (JNJ) is set to acquire Yellow Jersey Therapeutics, which holds NM26 rights, from Numab's...
US, European nations consider vaccinating workers exposed to bird flu
Reuters via Yahoo News· 3 days agoThe United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that...
In the Wake of 'Amgen v. Sanofi,' the USPTO Clarifies the Patent Enablement Requirement | The Legal...
Law.com· 6 days agoThe Supreme Court unanimously affirmed the determination that Amgen’s claims covering a genus of...
Robin Arzón on Her Family Legacy: “I'm Standing On the Shoulders of Giants”
Parents via Yahoo News· 5 hours agoThe vice president of fitness and programming at Peloton shares her family mantra, lessons on...
3 High-Yielding Dividend Stocks On Euronext Paris With Up To 4.2% Yield
Simply Wall St. via Yahoo Finance· 1 day agoIn recent trading sessions, France's CAC 40 Index has experienced a modest decline of 0.89%,...
France against Servier selling generics unit Biogaran, PM says
Reuters via AOL· 1 day agoPARIS (Reuters) -The French government has told drugmaker Servier it is against any sale of its...
3 Top Euronext Paris Dividend Stocks Offering Up To 6.2% Yield
Simply Wall St. via Yahoo Finance· 9 hours agoAmidst a backdrop of mixed performances across global markets, France's CAC 40 Index saw a modest...
Cell therapy reckoning: Pivot to autoimmune leaves unmet need in oncology
FierceBiotech· 1 hour agoThis story is part 2 in a four-part series about cell therapy created by the Fierce Biotech team....
Chutes & Ladders—CRISPR Therapeutics finds new CMO in Sanofi leader
FierceBiotech· 6 days agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
5 stocks that are back from the dead
Financial Post via Yahoo Finance· 5 hours agoEarlier this year, the company’s auditors put out a “going concern” note, indicating the company might not be able to survive. The stock was US$3 earlier...
